Neoadjuvant ADC Shows Activity in Phase 2 Muscle-Invasive Bladder Cancer Trial - Oncology News Central
Neoadjuvant ADC Shows Activity in Phase 2 Muscle-Invasive Bladder Cancer Trial Oncology News Central
Bladder Cancer News
ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates - CancerNetwork
ctDNA MRD Guidance in Bladder Cancer: Pharmacy Specialist on NCCN Updates CancerNetwork
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation - Urology Times
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation Urology Times
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms - Memorial Sloan Kettering Cancer Center
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms Memorial Sloan Kettering Cancer Center
CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances - The American Journal of Managed Care® (AJMC®)
CAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances The American Journal of Managed Care® (AJMC®)
Bladder Cancer: What You Need to Know to Detect It Early - Dana-Farber Cancer Institute
Bladder Cancer: What You Need to Know to Detect It Early Dana-Farber Cancer Institute
Pfizer (PFE) Wins FDA Approval For First Platinum Free Bladder Cancer Regimen - Yahoo Finance
Pfizer (PFE) Wins FDA Approval For First Platinum Free Bladder Cancer Regimen Yahoo Finance
New Neoadjuvant Bladder Cancer Therapy Approaches Transform Care - EMJ
New Neoadjuvant Bladder Cancer Therapy Approaches Transform Care EMJ
A new sensor could enable earlier detection of bladder cancer - MIT News
A new sensor could enable earlier detection of bladder cancer MIT News
Liang Cheng: Can You Predict FGFR3 Mutations in Bladder Cancer Based on Morphology? - Oncodaily
Liang Cheng: Can You Predict FGFR3 Mutations in Bladder Cancer Based on Morphology? Oncodaily
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer - ASCO Publications
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer ASCO Publications
Immune Biomarkers May Predict Response to Bladder Cancer Treatment - Northwestern University
Immune Biomarkers May Predict Response to Bladder Cancer Treatment Northwestern University
A Urine Test That Could Change the Course of Bladder Cancer Care - Stanford Medicine
A Urine Test That Could Change the Course of Bladder Cancer Care Stanford Medicine
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy - UT MD Anderson
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy UT MD Anderson
Overcoming ctDNA MRD Payer Gaps and Operational Hurdles in Bladder Cancer - CancerNetwork
Overcoming ctDNA MRD Payer Gaps and Operational Hurdles in Bladder Cancer CancerNetwork
Matthew Galsky, MD, explains the significance of perioperative EV/pembro in MIBC - Urology Times
Matthew Galsky, MD, explains the significance of perioperative EV/pembro in MIBC Urology Times
Key Bladder Cancer Trials to Watch in 2026 - Oncology News Central
Key Bladder Cancer Trials to Watch in 2026 Oncology News Central
Maite Bourlon: Experts Debate Precision Treatment Options for Prostate and Bladder Cancer - Oncodaily
Maite Bourlon: Experts Debate Precision Treatment Options for Prostate and Bladder Cancer Oncodaily
How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment? - CancerNetwork
How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment? CancerNetwork
First Assist: The evolving role of cystectomy in bladder cancer - Urology Times
First Assist: The evolving role of cystectomy in bladder cancer Urology Times
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial - Nature
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial Nature
Explained: Bladder cancer - Northside Hospital
Explained: Bladder cancer Northside Hospital
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. - AstraZeneca
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. AstraZeneca
Beyond the diagnosis: What living with bladder cancer really looks like - Johnson & Johnson
Beyond the diagnosis: What living with bladder cancer really looks like Johnson & Johnson
FDA Clears IND For UGN-501 in Non-Muscle Invasive Bladder Cancer - CancerNetwork
FDA Clears IND For UGN-501 in Non-Muscle Invasive Bladder Cancer CancerNetwork
Bladder Cancer Treatment Is Changing: What Patients Should Know - Cure Today
Bladder Cancer Treatment Is Changing: What Patients Should Know Cure Today
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery - Fox Chase Cancer Center
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery Fox Chase Cancer Center
Algae Microrobots Battle Bladder Cancer - the-scientist.com
Algae Microrobots Battle Bladder Cancer the-scientist.com
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms - ASCO Publications
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms ASCO Publications
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial - AstraZeneca
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial AstraZeneca
ASCO 2026: Discussant – Curing Early Bladder Cancer with Multidisciplinary Approaches - UroToday
ASCO 2026: Discussant – Curing Early Bladder Cancer with Multidisciplinary Approaches UroToday
ASCO 2026: New Approaches to Curing Bladder and Kidney Cancers: Where Do We Stand Today? - UroToday
ASCO 2026: New Approaches to Curing Bladder and Kidney Cancers: Where Do We Stand Today? UroToday
Study finds link between colorblindness and death from bladder cancer - Stanford Medicine
Study finds link between colorblindness and death from bladder cancer Stanford Medicine
Preop ctDNA May Identify Aggressive Bladder Cancer Better Than Nodal Status - Renal and Urology News
Preop ctDNA May Identify Aggressive Bladder Cancer Better Than Nodal Status Renal and Urology News
UroGen Pharma's ZUSDURI sales jump 109% as it s... - Pluang
UroGen Pharma's ZUSDURI sales jump 109% as it s... Pluang
New study looks at pesticide exposure and bladder cancer risk among Hmong farmworkers - UC Davis Health
New study looks at pesticide exposure and bladder cancer risk among Hmong farmworkers UC Davis Health
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models - Rockefeller University Press
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models Rockefeller University Press
Deion Sanders partly attributes Colorado's woeful 2025 season to bladder cancer but believes he has 'swagger' back - Yahoo Sports
Deion Sanders partly attributes Colorado's woeful 2025 season to bladder cancer but believes he has 'swagger' back Yahoo Sports
Five stories. One fight. What it means to live with bladder cancer. - Johnson & Johnson
Five stories. One fight. What it means to live with bladder cancer. Johnson & Johnson
Immunotherapy Shows Early Promise in Sparing Cancer Patients From Bladder Removal - NYU Langone Health
Immunotherapy Shows Early Promise in Sparing Cancer Patients From Bladder Removal NYU Langone Health